CoreCap Advisors’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

CoreCap Advisors’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	–	–	2335
2022 Q2	$0	Buy	+10	New	+$328	﹤0.01%	2354
2022 Q1	–	Sell	-77	Closed	-$3K	–	2327
2021 Q4	$3K	Buy	+77	New	+$2.69K	﹤0.01%	1915

CoreCap Advisors's IEIH Position: Q3 2022 in Review

CoreCap Advisors sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 10 shares.

CoreCap Advisors first reported a position in IEIH in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2021. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

CoreCap Advisors reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
CoreCap Advisors sold 10 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022.
CoreCap Advisors first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q4 2021 and held it in 2 quarters.
CoreCap Advisors's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $3K in Q4 2021.
0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on CoreCap Advisors's 13F filing for Q3 2022, filed 10 Feb 2023.